Cardiac contractility modulation with the impulse dynamics signal: Studies in dogs with chronic heart failure

Heart Failure Reviews

Volumn 6, Issue 1, 2001, Pages 45-53

  Sabbah, Hani N ^a   Haddad, Walid ^b   Mika, Yuval ^b   Nass, Omar ^a   Aviv, Ricardo ^b   Sharov, Victor G ^a   Maltsev, Victor ^a   Felzen, Bella ^b   Undrovinas, Albertas I ^a   Goldstein, Sidney ^a   Darvish, Nissim ^b   Ben Haim, Shlomo A ^b,c  

^a HENRY FORD HEART AND VASCULAR INSTITUTE   (United States)

^b Impulse Dynamics   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Animal models; Congestive heart failure; Contractility; Ventricular function

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM ION; INOTROPIC AGENT; PHOSPHODIESTERASE INHIBITOR;

AMPLITUDE MODULATION; CALCIUM SIGNALING; CHRONOTROPISM; CONFERENCE PAPER; DISEASE MODEL; DOG; DRUG EFFICACY; DRUG SAFETY; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART OUTPUT; HEART PROARRHYTHMIA; HUMAN; INOTROPISM; LONG TERM CARE; MICROEMBOLISM; MORTALITY; NONHUMAN; QUALITY OF LIFE; SIGNAL TRANSDUCTION;

ANIMALS; DOGS; ELECTRIC STIMULATION THERAPY; HEART FAILURE, CONGESTIVE; MYOCARDIAL CONTRACTION; VENTRICULAR FUNCTION, LEFT;

EID: 0035055510     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009855208097     Document Type: Conference Paper

References (25)

1. Vasodilator and inotropic drugs for the treatment of chronic heart failure: Distinguishing hype from hope
2. The pharmacologic treatment of chronic congestive heart failure
3. Intermittent infusion of dobutamine in the therapy of severe congestive heart failure-long-term effects and the lack of tolerance
4. Phosphodiesterase inhibitors: Alterations in systemic and coronary hemodynamics
5. Myocardial concentration of norepinephrine and cyclic AMP in ventricular fibrillation during acute myocardial ischemia
6. Potential arrhythmogenic role of cyclic adenosine monophosphate (AMP) and cytosolic calcium overload: Implications for prophylactic effects of beta-blockers in myocardial infarction and proarrhythmic effects of phosphodiesterase inhibitors
7. Electrophysiologic and proarrhythmic effects of intravenous inotropic agents
8. Proarrhythmic effects of intravenous vasopressors
9. Characterization of the inotropic and arrhythmogenic action of the sodium channel activator BDF 9148: A comparison to its S-enantiomer BDF 9196, to its congener DPI 201-106, to norepinephrine, and to ouabain
10. Investigation of the mechanism of the positive inotropic action of BDF 9148; Comparison with DPI 201-106 and the enantiomers
11. Cardiac sodium channels as targets for new inotropic agents
12. The role of sodium channels in the effect of the cardiotonic compound DPI 201-106 on contractility and membrane potentials in isolated mammalian heart preparation
13. BDF 9148: Comparison of action potential duration in vitro and prolongation of Q-T interval in anesthetized dogs (time course study)
14. The effect of a new inotropic agent, DPI 201-106, on systolic time intervals and the electrocardiogram in healthy subjects
15. QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest
16. Postextrasystolic potentiation. Do we really know what it means and how to use it?
17. The inotropic action of paired pulse stimulation in the normal and failing heart: An experimental study
18. Effects of postextrasystolic potentiation on normal and failing hearts
19. Delivery of non-excitatory contractility-modulation electric signals improve left ventricular performance in dogs with heart failure
20. A canine model of chronic heart failure produced by multiple sequential coronary microembolizations
21. Effects of long-term monotherapy with enalapril, metoprolol and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction
22. Hemodynamic effects of a novel sodium channel activator in dogs with chronic heart failure
23. Abnormal electrical properties of myocytes from chronically infarcted canine heart. Alterations in Vmax and the transient outward current
24. 2+ transient in cardiomyocytes of dogs with chronic heart failure